帝王国际投资2024年年报

(formerly known as Life Healthcare Group Limited) ANNUAL REPORT2024 Contents Corporate Information2Management Discussion and Analysis6Biographical Details of Directors and Senior Management30Directors’ Repor t36Corporate Governance Repor t58Independent Auditor’s Repor t84Consolidated Statement of Profit or Loss andOther Comprehensive Income95Consolidated Statement of Financial Position97Consolidated Statement of Changes in Equity99Consolidated Statement of Cash Flows100Notes to the Consolidated Financial Statements102Five Year Financial Summary184 Corporate Information EXECUTIVE DIRECTORS Mr. Wang Mengyao(Chairman) (appointed on 9 August 2023,re-designated as Co Chairman on 28 December 2023 andre-designated as Chairman on 19 January 2024) Mr. Liu Mingqing(Co-Chairman and Chief Executive Officer)(appointed as Chief Executive Officer on 22 August 2023,re-designated as Chairman on 18 December 2023 andre-designated as Co Chairman on 28 December 2023) Mr. Lu Xingwu (appointed on 28 December 2023) Mr. Gu Jianguo (appointed as Independent Non-Executive Directoron 22 August 2023 and re-designated as Executive Directoron 19 March 2024)Mr. Man Wai LunMr. Pang ZhenMs. Yan Ming (appointed as Independent Non-Executive Directoron 23 August 2023 and re-designated as Executive Directoron 19 March 2024)Mr. Yuan Limin (resigned on 23 August 2023) Mr. Huang Zhi fang (resigned on 24 July 2023) Mr. Long Jinbo (appointed on 18 December 2023 and resignedon 19 March 2024) INDEPENDENT NON-EXECUTIVE DIRECTORS Ms. Yang Xilin (appointed on 23 August 2023) Mr. Lou Tao (appointed on 18 December 2023) Mr. Zheng Yu (appointed on 19 March 2024) Mr. Wang Zhenyu (appointed on 19 March 2024) Dr. Wang, Bruce Xianliang (resigned on 23 August 2023) Corporate Information AUDIT COMMITTEE Ms. Yang Xilin(Chairman) (appointed on 23 August 2023) Mr. Zheng Yu (appointed on 19 March 2024) Mr. Wang Zhenyu (appointed on 19 March 2024) Mr. Gu Jianguo (appointed on 22 August 2023 andresigned on 19 March 2024) Dr. Wang, Bruce Xianliang (resigned on 23 August 2023) Dr. Zhao, Shawn Xiaohong (resigned on 23 August 2023) REMUNERATION COMMITTEE Ms. Yang Xilin(Chairman) (appointed on 23 August 2023 andre-designated as Chairman on 19 March 2024) Mr. Zheng Yu (appointed on 19 March 2024) Mr. Gu Jianguo (appointed on 22 August 2023) Ms. Yan Ming (appointed on 23 August 2023 andresigned on 19 March 2024) Dr. Wang, Bruce Xianliang (resigned on 23 August 2023) Dr. Zhao, Shawn Xiaohong (resigned on 23 August 2023) NOMINATION COMMITTEE Mr. Zheng Yu(Chairman) (appointed on 19 March 2024) Ms. Yang Xilin (appointed on 23 August 2023) Mr. Man Wai LunMr. Gu Jianguo (appointed on 22 August 2023 andresigned on 19 March 2024) Dr. Wang, Bruce Xianliang (resigned on 23 August 2023) Corporate Information AUTHORISED REPRESENTATIVES Mr. Liu MingqingMr. Wong Ka Sing (appointed on 14 March 2024) COMPANY SECRETARY Mr. Wong Ka Sing (appointed on 14 March 2024) 38223 AUDITOR ZHONGHUI ANDA CPA Limited23/F, Tower 2, Enterprise Square Five38 Wang Chiu RoadKowloon Bay, KowloonHong Kong PRINCIPAL BANKERBank of Communications (Hong Kong) Limited Cricket Square, Hutchins DriveP.O. Box 2681Grand Cayman KY1-1111Cayman Islands REGISTERED OFFICE Cricket Square, Hutchins DriveP.O. Box 2681Grand Cayman KY1-1111Cayman Islands PRINCIPAL OFFICE IN HONG KONG Suite 2001, 20/FTwo Chinachem Exchange SquareNo. 338 King’s RoadNor th PointHong Kong 3382202001 www.kinginternational.hk COMPANY’S WEBSITEwww.kinginternational.hk Corporate Information CAYMAN ISLANDS PRINCIPAL SHAREREGISTRAR AND TRANSFER OFFICE Suntera (Cayman) LimitedCricket SquareHutchins DriveP.O. Box 2681Grand CaymanKY1-1111Cayman Islands Suntera (Cayman) LimitedCricket SquareHutchins DriveP.O. Box 2681Grand CaymanKY1-1111Cayman Islands HONG KONG BRANCH SHARE REGISTRARAND TRANSFER OFFICE 1617 Tricor Tengis Limited17/F, Far East Finance Centre16 Harcour t RoadHong Kong 00928 LISTING INFORMATION The Stock Exchange of Hong Kong LimitedStock Code: 00928 Management Discussion and Analysis Onbehalf of King International Investment Limited(the“Company”),Ipresent to the shareholders the results of the Company and itssubsidiaries (collectively referred to as the “Group”) for the year ended31 March 2024. OVERVIEW The Company is an investment holding company. The Company and itssubsidiaries (the “Group”) are principally engaged in healthcare productsand services business, money lending business and sales of liquor Business. On one hand, the Company, through its subsidiaries, provides medicalsuppliesincluding medical thermometers,masks,protective clothing,disinfectant, virus testing kits and reagents, breathing machines and othermedical products, and also provides value-added services in respect of theprocurement of such medical supplies and products including providingmarket intelligence, sourcing of bids, comparative assessment of technicalspecifications and cost analysis, and negotiation